Contracts › 75N93024C00018
75N93024C00018: Design and Engineering of Vesivax Hiv Immunogen Formulations
Awarded to Molecular Express, Inc by National Institutes of Health (NIH).
$2.0Mobligated
$2.0Mpotential value
31 August 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93024C00018 |
|---|---|
| Awardee | Molecular Express, Inc |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | CA |
| Offers received | 2 |
| Period of performance | 01 July 2024 to 31 August 2026 |
| Potential end | 31 August 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record